KRRO – korro bio, inc. (US:NASDAQ)
Stock Stats
News
Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update
Korro Bio, Inc. (NASDAQ: KRRO) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $155.00 price target on the stock.
Korro to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Korro Bio, Inc. (NASDAQ: KRRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $115.00 price target on the stock.
Korro to Participate in Upcoming Investor Conferences
Form SCHEDULE 13G/A Korro Bio, Inc. Filed by: CITADEL ADVISORS LLC
Form SCHEDULE 13G Korro Bio, Inc. Filed by: DRIEHAUS CAPITAL MANAGEMENT LLC
Form 3 Korro Bio, Inc. For: Feb 11 Filed by: Dolan Oliver
Form 8-K Korro Bio, Inc. For: Feb 11
Form 4 Korro Bio, Inc. For: Feb 03 Filed by: Cerio Jeffrey
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.